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Abstract
Low mole fractions of viral fusion peptides induce inverted cubic (QII) phases in dipalmitoleoylphosphatidylethanolamine
(DiPoPE), a lipid with unsaturated acyl chains that normally forms inverted hexagonal phase (HII) above 43‡C. The ability
to form a QII phase is relevant to the study of membrane fusion: fusion occurs in liposomal systems under conditions where
QII phase precursors form, and fusion may be an obligatory step in the lamellar (LK)/QII phase transition. We used X-ray
diffraction and time-resolved cryoelectron microscopy (TRC-TEM) to study the effects of the influenza hemagglutinin fusion
peptide on the phase behavior and structure of DiPoPE. X-ray diffraction data show that at concentrations of 3^7 mol%, the
fusion peptide (FP) induces formation of a QII phase in preference to the HII phase. TRC-TEM data show that the FP acts at
early stages in the phase transition (i.e. within seconds) : at 2^7 mol%, FP decreases or inhibits formation of the LK/HII
intermediate morphology observed via TRC-TEM in pure DiPoPE at the same temperature. Our X-ray diffraction data
imply that FP either does not affect, or slightly increases, the spontaneous curvature of the host lipid (i.e. either does not
affect or tends to destabilize inverted phases, respectively). FP may act in part by affecting the relative stability of two
intermediate structures in the phase transition mechanism, as suggested previously. These results indicate a new way in which
hydrophobic sequences of membrane proteins may be fusogenic. ß 2000 Elsevier Science B.V. All rights reserved.
1. Introduction
When added to phosphatidylethanolamines, low
mole fractions of fusion peptides of some viral fusion
proteins [1,2], as well as the amphipathic helical pep-
tide alamethicin [3], induce QII phases that do not
spontaneously form in the absence of the peptides.
The mechanism of this peptide e¡ect is of great in-
terest because membrane fusion may be an obliga-
tory step in the lamellar/inverted cubic (LK/QII)
phase transition [4,5], and the fusion peptides of viral
proteins are critical for the membrane fusion activity
of the proteins. Several authors have previously
shown that viral fusion peptides increase the fre-
quency of structures associated with the LK/QII phase
transition (e.g. [6^8]). Previously we used time-re-
solved cryoelectron microscopy (TRC-TEM) to
study the intermediates in the LK/inverted hexagonal
(HII) phase transition in large unilamellar vesicle
(LUV) dispersions of DiPoPE [9]. In the present
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work, our aim is to determine how a well-studied
viral fusion peptide a¡ects the formation of the QII
phase and of the early intermediates in this phase
transition. In addition, we evaluated the relationships
between these e¡ects and membrane fusion proc-
esses.
2. Materials and methods
2.1. Materials
The phospholipid used in this study, dipalmitoleo-
yl phosphatidylethanolamine (DiPoPE), a lipid com-
posed of 16:1 acyl chains, was purchased from Avan-
ti Polar Lipids (Alabaster, AL), and used without
further puri¢cation. The 20-amino acid N-terminal
in£uenza fusion peptide (X31 strain of in£uenza vi-
rus; sequence GLFGAIAGFIENGWEGMIDG-
amide) was made by standard solid phase synthetic
methods using FMOC chemistry. The ¢nal puri¢ca-
tion of the peptide was on a Hamilton PRP-1 HPLC
column. The peptide was applied to the column in a
solution of DMSO, TFE, 0.1 M ammonium acetate
(1:2:2, v/v/v) and the eluant was a gradient contain-
ing water, ammonium acetate and acetonitrile, with
increasing acetonitrile concentrations. The fractions
containing the puri¢ed peptide were then lyophilized
to dryness. The identity of the peptide was veri¢ed
by fast bombardment mass spectrometry and by ami-
no acid analysis.
2.2. Preparation of peptide/DiPoPE LUVs
The fusion peptide (FP) was dissolved in metha-
nol, and the FP concentration was determined on the
basis of the tryptophan absorbance at 280 nm. (The
extinction coe⁄cient at 280 nm of Boc-Trp in meth-
anol was veri¢ed as being 5550 M31 cm31. This val-
ue was used for the extinction coe⁄cient of FP.) An
appropriate volume of this stock solution was mixed
rapidly with a chloroform/methanol (3/1 v/v) solu-
tion of phospholipid. The volume of the phospholip-
id solution was equal to or greater than the peptide
solution. The mixture was dried under vacuum in a
rotary evaporator for 1 h, then hydrated in the gly-
cine bu¡er (20 mM glycine, 150 mM NaCl, 0.2 mM
EDTA, pH 9.6) to yield a lipid concentration of
1.1 mg/ml and then subjected to three freeze/thaw
cycles (dry ice/room temperature water). The pH
was measured after the freeze/thaw cycles and ad-
justed if necessary. The suspension was then extruded
ten times, using two 100-nm polycarbonate ¢lters
(Nucleopore, Pleasanton, CA) in a stainless steel bar-
rel extruder (Lipex Biomembranes, Vancouver, BC).
The ¢lters of the extruder usually clogged during the
¢rst extrusion: a pressure of up to 700 psi was nec-
essary to extrude. After replacement of the ¢lters and
¢lter support, subsequent extrusion was facile
(300 psi). The pH was checked again after extrusion.
The FP concentration of the ¢nal LUV dispersion
was estimated on the basis of the tryptophan absor-
bance using a PE LUV or bu¡er blank. Approxi-
mately 0.3 mg of the FP was lost on the ¢lters and
¢lter support, at each of several peptide concentra-
tions. In calculating the peptide/lipid ratio, it was
assumed that no lipid was lost on the ¢lters. The
nominal total mole percent of FP is calculated on a
lipid basis, and is accurate to within about þ 0.4% at
2 mol%, and þ 1 mol% at higher concentrations. The
LUV preparation was stored on ice or in the refrig-
erator, sealed under Argon, until used (generally
within 24 h).
2.3. Preparation of LUVs for di¡erential scanning
calorimetry (DSC)
This followed roughly the same procedure as for
FP/DiPoPE LUVs (see above), except that no pep-
tide was added and the lipid was dried down from a
chloroform solution. The ¢nal lipid concentration
was made to 2.2 mg lipid/ml.
2.4. DSC
A sample of DiPoPE LUVs was loaded into a
sample cell of a Nano Di¡erential Scanning Calorim-
eter (CSC Sciences, Provo, UT) which had been pre-
cooled to 0‡C. It was acidi¢ed inside the sample cell
of a DSC using an equal volume of ice-cold 50 mM
acetate bu¡er, 120 mM NaCl, 0.1 mM EDTA, pH
4.5. The ¢nal pH of the acidi¢ed lipid was 5.0. The
features of the design of the Nano Di¡erential Scan-
ning Calorimeter have been described [10]. The two
solutions were separately degassed under vacuum, on
ice, prior to loading in the calorimeter cells.
BBAMEM 77907 21-9-00
D.P. Siegel, R.M. Epand / Biochimica et Biophysica Acta 1468 (2000) 87^9888
2.5. Preparation of samples for X-ray di¡raction
A dilute solution of the in£uenza fusion peptide
was made in methanol. The solution was sometimes
slightly hazy. It was then mixed with a solution of
DiPoPE in CHCl3/MeOH (2/1; v/v) at which point
the mixture became more transparent. A portion of
the solvent was evaporated and the remaining solu-
tion was transferred to an X-ray capillary. The re-
mainder of the solvent was then evaporated and last
traces of solvent removed overnight under vacuum.
The resulting deposit, containing 10 mg of lipid, was
hydrated with 20 Wl of bu¡er at pH 5.0 containing
50 mM acetate, 20 mM glycine, 135 mM NaCl and
0.15 mM EDTA. This bu¡er corresponds to the pH
and composition of the ¢nal bu¡er suspending the
lipid in TRC-TEM experiments (see below). The re-
sulting paste was mechanically mixed with a ¢ne met-
al wire and brought to the bottom of the capillary by
centrifugation. The sample was put under Argon and
the capillary was sealed and allowed to equilibrate
several hours at room temperature.
2.6. X-ray di¡raction experiments
A Rigaku-Denki (Model RU-200B) rotating anode
was used to obtain nickel-¢ltered Cu KK radiation of
V= 1.54 Aî . X-rays were focused using a Frank’s type
camera and recorded with a TEC (Model 205) posi-
tion sensitive proportional counter [11]. Calibration
was done with freshly recrystallized samples of non-
adecane, taking the spacings for this standard as
26.2 Aî . Unoriented samples were measured in
1.5 mm outer-diameter glass capillaries. The speci-
men temperature was controlled to þ 0.5‡C with a
thermoelectric device. The specimens were allowed to
equilibrate at each temperature for at least 10 min
and the di¡raction collected over a period in the
range of 20^200 min. Generally, cubic phases re-
quired longer collection times because of the weak
intensity of the di¡raction. The measured d-spacing
is calculated from the average of all easily resolvable
orders. Reported spacings are accurate to þ 0.5 Aî
for lattices up to about 80 Aî and to þ 2 Aî for larger
lattices.
2.7. TRC-TEM
The same methods were used as in [9], except that
a Philips CM-120 microscope with an accelerating
voltage of 120 kV, a 70-Wm objective aperture, and
a Gatan cold stage (which maintained the specimens
at 3180‡C) were used. EM grids (300-mesh copper
with a lacy carbon ¢lm; Ted Pella) were mounted in
a CEVS [12] at a temperature constant to within
þ 1‡C and a relative humidity near 100%. A 4-Wl
drop of LUV suspension was placed on a TEM
grid using a micropipetor. A second 4-Wl drop of
low-pH bu¡er, 120 mM NaCl, 50 mM sodium ace-
tate, pH 4.5, 0.1 mM EDTA, was then mixed with it.
The grid was blotted to form a thin aqueous ¢lm,
and the grid was immediately plunged into liquid
ethane. (It was con¢rmed that mixing equal volumes
of glycine and acetate bu¡ers yields a ¢nal pH of 5,
and that the pH is still 5.5 even if the bu¡ers are
mixed in a 5/4 glycine/acetate volume ratio.) The
grid was loaded into the cold stage under liquid N2
and examined via TEM. Kodak SO-163 ¢lm was
used and was developed in D-19 for 12 min. An
underfocus of ‘1.7 Wm was set for most exposures,
though ‘1.9 Wm was used for some images of the pH
9.6 dispersions.
3. Results and discussion
3.1. X-ray di¡raction
Typical one-dimensional X-ray di¡raction patterns
of DiPoPE with and without FP, collected at 55‡C,
are shown (Fig. 1). The top curve of pure DiPoPE
Table 1
X-ray di¡raction results for pure DiPoPE
Temperature (‡C) Phase(s) present Unit cell (nm)
25 L 4.92
35 L 4.82





Re-cooled to 25 L 4.91
Note: in all the tables, L stands for lamellar (LK) phase, HII
for inverted hexagonal phase, and QII for inverted cubic phase.
Also, the unit cell constant for the HII phase is given as the di-
ameter of the HII tubes ( = 2d10/k3).
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shows only the ¢rst three re£ections from an HII
phase. The middle curve, of DiPoPE containing
3 mol% FP, shows re£ections due to the HII phase
along with weaker re£ections from a QII phase. The
bottom di¡ractogram is from DiPoPE containing
7 mol% FP, and shows only re£ections from a QII
phase. Data collected from samples of di¡erent pep-
tide concentrations are collated in Tables 1^3. The
data in Table 1 were collected from a single sample
of pure DiPoPE as a function of increasing temper-
ature, as described in Section 2. The data are consis-
tent with the occurrence of an LK/HII phase transi-
tion at a temperature between 35 and 42‡C,
consistent with past observations (e.g. [9,13]). The
unit cell dimensions (LK phase, bilayer repeat spac-
ing; HII phase, HII tube diameter) were determined
from the ¢rst lamellar re£ection and the ¢rst three
HII re£ections, respectively, in all cases. This lipid
does not form an LL phase in liquid water. When
the sample was cooled back to 25‡C from 65‡C,
the transition reversed to produce only the LK phase.
Di¡raction results from a sample containing 3 mol%
FP in DiPoPE are listed in Table 2. Here the behav-
ior is obviously di¡erent. The temperature of the LK/
HII phase transition is broadened to higher temper-
atures, occurring between 36 and 55‡C. Traces of a
QII phase were observed in this sample starting at
55‡C. Since only one long spacing was observed (at
ca. 8.5 nm), the assignment is tentative. However, at
65‡C, four re£ections are observed that index as a
Pn3m QII phase. Evidence for a QII phase has pre-
viously been observed in DiPoPE containing 1 mol%
of the same peptide at a similar temperature [2], and
this same type of QII phase can be induced in some
pure phosphatidylethanolamine systems by tempera-
ture-cycling [14,15]. Upon cooling to 25‡C, weak re-
£ections corresponding to QII and LK phase lattices
were observed. Similar phase behavior was observed
in a sample containing 3.2 mol% FP. Interestingly,
this sample was heated more rapidly (a smaller num-
ber of steps at larger temperature intervals), and only
a weaker, single re£ection from a QII lattice was
observed (data not shown). Both of these latter two
sets of observations are consistent with the sluggish
kinetics and hysteresis often observed in LK/QII
phase transitions in phosphatidylethanolamine (PE)
and PE-derivative systems [14^18], as well as in a PE
Fig. 1. One-dimensional di¡raction patterns obtained from pure
DiPoPE and FP/DiPoPE mixtures at 55‡C. Top: pure DiPoPE.
Middle: DiPoPE containing 3 mol% FP. Bottom: DiPoPE con-
taining 7 mol% FP.
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derivative that also contained low concentrations of
hydrophobic peptides [19].
Results of X-ray di¡raction experiments on sam-
ples containing 7 mol% FP are shown in Table 3. In
this case, the re£ections were too broad to reliably
determine the lattice constants of the LK and HII
phases. Only LK phase re£ections were observed at
low temperatures, a broad LK/HII transition com-
menced at around 41‡C and lasted at least until
47‡C, and traces of a Pn3m QII lattice appeared at
41‡C, becoming well-de¢ned at 50‡C and higher tem-
peratures. This is very similar to the phase behavior
observed in the 3 mol% FP sample (Table 2). Hence
it is clear that low concentrations of FP are capable
of inducing formation of a Pn3m QII phase that does
not form in pure DiPoPE under the same circum-
Table 3
X-ray di¡raction results for 7 mol% FP in DiPoPE
Temperature
(‡C)







41 L/HII (?) ? A single broad re£ection at 5.75 nm may include both L and HII phase
re£ections. Only a single QII re£ection observed (10.9 nm)
QII (?) 15.4
43 L/HII (?) ? As above: for L and HII, only a single broad re£ection was observed at 5.58 nm
QII (?) 15.8
47 L/HII (?) ? As above: for L and HII, only a single broad re£ection was observed at 5.40 nm
QII (?) 15.3
50 QII (Pn3m) 14.4 Four re£ections indexing as a Pn3m QII lattice
55 QII (Pn3m) 13.6 Four re£ections indexing as a Pn3m QII lattice
60 QII (Pn3m) 12.3 Four re£ections indexing as a Pn3m QII lattice
Table 2
X-ray di¡raction results for 3 mol% FP in DiPoPE
Temperature
(‡C)








42 L (minor) 5.09
HII 7.09
45 L (trace) 4.95
HII 7.03
50 L (trace) 4.87
HII 6.92
55 HII 6.85 Only one re£ection for QII (assumed Pn3m)
QII 12.0
65 HII 6.69 Four of the ¢rst ¢ve re£ections indexing as a Pn3m phase (k2, k3, k6, and k8)
QII (Pn3m) 11.4




D.P. Siegel, R.M. Epand / Biochimica et Biophysica Acta 1468 (2000) 87^98 91
stances. Recent experience with QII phases in both
pure lipid [15,17,18] and peptide^lipid [19] systems
suggests that the lattice constants of the ¢rst QII
phases to form either with increasing temperature
or increasing incubation time at a constant temper-
ature can initially be much larger than the values
measured here. It is possible that QII phases might
be forming at lower temperatures in this system, with
the lowest-angle (and most easily observable) re£ec-
tions occurring at angles too small to be detected by
the present apparatus.
Inspection of Tables 1^3 shows that addition of
FP at low concentrations increases the interlamellar
spacing in the LK phase relative to pure DiPoPE, by
as much as 0.4 nm at 7 mol%. Interestingly, the
lattice constant of the HII phase at 45‡C is almost
the same in the 3 mol% FP samples as in the pure
DiPoPE sample (to within 0.1 nm). Therefore, the
peptide is either not partitioning into the HII phase,
or is not a¡ecting the spontaneous radius of curva-
ture of the DiPoPE host lipid, or there are counter-
balancing e¡ects of electrostatic repulsion by the
peptide increasing the spontaneous curvature, while
other peptide^lipid interactions decrease it. However,
in general, the equilibrium HII tube diameter would
be expected to change if the peptide changed the
spontaneous curvature of DiPoPE [20,21]: an incre-
ment in spontaneous curvature would be observed as
an increment in HII tube diameter. The addition of
7 mol% of FP increases the onset temperature for for-
mation of HII phase, which shows that the FP is not
phase separating into a peptide-rich lamellar phase at
lower temperatures, but increases the LK/HII phase
transition temperature of a uniform lipid/FP mixture.
A reduction in spontaneous curvature would be ex-
pected to decrease the onset temperature [21]. To-
gether, these two observations show that, in this con-
centration range, the FP does not stabilize non-
lamellar phases by reducing the spontaneous radius
of curvature of the host lipid. This is in contrast to
results obtained at lower fusion peptide concentra-
tions in this [7] and other systems (e.g. [8,22]). If
anything, there is a small increase in spontaneous
curvature (i.e. favoring lamellar phase formation),
judging from the comparison of HII tube diameters
at constant temperature in Tables 1 and 2.
Fig. 2. Micrographs of DiPoPE and FP/DiPoPE LUV dispersions at pH 9.6 quenched from 26‡C. (A) DiPoPE LUVs produced using
the same protocol as for the FP/DiPoPE LUVs used in this work. The large black regions are strands of a lacy graphite ¢lm that sup-
ports the aqueous ¢lms. The predominant structures are LUVs about 40^70 nm in diameter. (B) FP/DiPoPE LUVs with 7 mol% FP.
Most of the structures are LUVs similar in size to those in (A), although some of the LUVs appear to have invaginated. (C) FP/Di-
PoPE LUV dispersion with 7 mol% FP after 18 days of storage at 4‡C. This ¢eld emphasizes the presence of a subpopulation of larg-
er vesicles, often consisting of oligolamellar vesicles or several vesicles enveloped by a larger one. Scale bars: 100 nm.
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3.2. TRC-TEM data
Fig. 2 shows micrographs of DiPoPE and FP/Di-
PoPE dispersions at pH 9.6, quench frozen from
26‡C. Fig. 2A is a micrograph of a dispersion of
DiPoPE LUVs produced by the same method used
to generate FP/DiPoPE LUVs. The large black re-
gions are strands of the lacy graphite ¢lm that sup-
ports the thin aqueous ¢lms prior to vitri¢cation.
The structures visible in the vitri¢ed ¢lms are pre-
dominantly LUVs with diameters of 40^70 nm. Fig.
2B shows FP/DiPoPE LUVs with 7 mol% FP. Most
of the structures in these images are also LUVs, some
of which appear to have invaginated. The specimen
in Fig. 2B was made from an LUV dispersion 3 days
after production. However, the specimen in Fig. 2C
was made from an 18-day-old LUV dispersion. In
this sample, there was a substantial subpopulation
of larger structures that are several tenths of a mi-
cron in diameter, often consisting of several vesicles
enveloped by a larger one, or of oligolamellar
vesicles in which the enclosed structures have com-
parable diameters. This growth in size of the lipid
aggregates might have been in£uenced by the accu-
mulation of lipid hydrolysis products (see ‘DSC
Data’, below).
Fig. 3 shows TRC-TEM images of specimens of
DiPoPE LUVs that were neutralized with acetate
bu¡er at a temperature of 31‡C, seconds before vit-
ri¢cation. The midpoint of the LK/HII transition of
freshly prepared, pH-neutralized DiPoPE LUVs as
determined via DSC (see below) is 42‡C. The same
intermediate morphology was observed as in [9], and
in both cases this morphology formed well below the
equilibrium TH. LUVs rearrange into large struc-
tures, with di¡erent types of interlamellar connec-
tions. At the left of Fig. 3A, many poorly ordered
interconnections between lamellae are visible. These
are probably transmonolayer contacts (TMCs;
[4,5,9]). The arrowheads indicate regions in which
quasihexagonal (QH) structure has formed: this
may correspond to the ordered TMC array postu-
lated in [9], as an intermediate in the LK/HII phase
transition. It is observed in DiPoPE only when the
Fig. 3. DiPoPE LUVs that were neutralized with acetate bu¡er at a temperature of 31‡C, seconds before vitri¢cation. (A) At the left
of the ¢gure, many poorly ordered interconnections between lamellae are visible. These are probably TMCs [4,5,9]. Arrowheads: re-
gions in which quasihexagonal structure has formed. This may correspond to the ordered TMC array postulated as an HII phase pre-
cursor [4,5,9]. Asterisk: a multilamellar vesicle (MLV). MLVs also form in these dispersions, and represent the equilibrium structure
at this temperature, as demonstrated by X-ray di¡raction (Table 1) and time-resolved NMR measurements [9]. (B) Same sample com-
position and temperature. Arrowheads: regions of better-ordered quasihexagonal structure than in (A). Asterisk: edge of an MLV.
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temperature is approximately 20‡C below TH or
higher. Catenoidal interlamellar attachments (ILAs,
[4,5,9]) are occasionally visible at the periphery of
some membrane assemblies. Fig. 3B is another image
of DiPoPE at pH 5 and 31‡C. The arrowheads in-
dicate larger regions of better-ordered quasihexago-
nal structure, and the asterisk again indicates an
MLV. Despite the abundance of non-lamellar struc-
tures in Fig. 3B,C, the LK phase is the equilibrium
phase at 31‡C, and time-resolved NMR measure-
ments [9] show that the non-lamellar morphology
that forms under these circumstances is transient,
with only lamellar phase DiPoPE being present with-
in about 1^2 min after neutralization. The specimens
in Fig. 3 were made using LUV dispersions produced
less than 24 h before specimen vitri¢cation.
Fig. 4A^D are micrographs of FP/DiPoPE disper-
sions with di¡erent concentrations of FP, neutralized
seconds before vitri¢cation, at the same temperature
as the pure DiPoPE specimens in Fig. 3 (31‡C). In
Fig. 4A, the FP concentration was 2 mol%. The QH
domains that are abundant in the DiPoPE LUV dis-
persion are still visible, but are very infrequent in this
sample (not shown). The most common lipidic struc-
tures are MLVs. There are small and infrequent in-
clusions of disordered intermediates, but these are
much rarer than in pure DiPoPE under the same
conditions. Fig. 4B is a micrograph of a neutralized
dispersion of 5 mol% FP in DiPoPE. The most com-
mon structures are LUVs and a few oligolamellar
vesicles. There are many fewer MLVs than in
2 mol% FP specimens. Most of the specimens con-
sisted of LUVs that were not extensively aggregated.
A denser-than-usual region was deliberately selected
here to emphasize the small change in LUV size and
structure in the presence of 5 mol% FP. Fig. 4C and
D are micrographs of 7 mol% FP/DiPoPE disper-
sions treated in the same way. Obviously, a further
increase in peptide concentration did not substan-
tially change the morphology observed at 5 mol%,
except that MLVs are even rarer at 7 mol%. At both
5 and 7 mol% FP, there are infrequent examples of
small clusters of disordered intermediates. Fig. 4A^D
were made from LUV dispersions that had been
stored for less than 24 h at 4‡C at the time of speci-
men vitri¢cation.
Fig. 4E is a micrograph of a neutralized 15 mol%
FP/DiPoPE dispersion, that was vitri¢ed at a lower
temperature of only 25‡C. At this, the highest FP
concentration we investigated, domains of disordered
intermediates were more frequent and larger in size
than at 2^7 mol%, despite the fact that the temper-
ature was lower. Many clear examples of ILAs are
seen in pro¢le at the periphery of these domains.
However, it is important to note that this specimen
was made from an LUV dispersion that had been
stored for 6 days at 4‡C: it is possible that extensive
hydrolysis of the DiPoPE during this time lowered
the TH value and also contributed to the more ex-
tensive intermediate formation in this specimen (see
below, under ‘DSC Data’). It is shown here to em-
phasize the existence of ILAs in such dispersions,
which are QII phase precursors [17].
The TRC-TEM data in Fig. 4 allow two conclu-
sions concerning the e¡ect of FP on inverted phase
formation. First, when FP/DiPoPE and DiPoPE sys-
tems are compared at constant temperature, the in-
termediate morphology associated with the LK/HII
phase transition [9] is rarer (2^3 mol%) or absent
(7 mol%) in the FP/DiPoPE specimens. This is con-
sistent with the X-ray di¡raction data (Tables 1 and
2), which show that addition of FP at 2 or 3 mol%
broadens the lamellar/non-lamellar transition to
higher temperatures, and, at 7 mol%, increases the
onset temperature for inverted phase formation. Sec-
ond, FP acts at an early stage in the lamellar/inverted
phase transition. At 2^3 mol% FP, where the onset
temperature of the lamellar/non-lamellar phase tran-
sition is nearly the same as in pure DiPoPE (Tables 1
and 2), FP reduces the extent of formation of inter-
mediates in the LK/HII and LK/QII transitions relative
to pure DiPoPE within the ¢rst few seconds after the
transition is triggered. This is consistent with our
earlier hypothesis [5,9] that hydrophobic peptides
like FP could induce QII phase formation, and de-
crease the rate and/or extent of HII phase formation.
Few LK/QII transition intermediates (ILAs) are visi-
ble in Fig. 4A^D because these images were obtained
within seconds after the pH was dropped, and the
LK/QII phase transition is notoriously slow (hours)
and hysteretic (e.g. [14,16^19]). However, it is also
possible that the peptide slows intermediate forma-
tion by hindering close apposition of the LK phase
bilayers, which would slow formation of the inter-
membrane intermediates. This could reduce the rate
of the transitions at constant temperature, and post-
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pone rapid formation of intermediates until higher
temperatures, since the rate and extent of intermedi-
ate formation should increase with increasing tem-
perature [4,5]. Such an e¡ect would be consistent
with the increase in LK phase interlamellar spacing
observed in the presence of FP (Tables 1^3).
3.3. DSC data
In order to prepare LUVs from PE, the lipid sus-
pension must ¢rst be brought to alkaline pH. In
some cases, the LUVs were maintained in alkaline
solution after extrusion so that they would be avail-
Fig. 4. DiPoPE LUV dispersions containing di¡erent concentrations of FP, all acidi¢ed to pH 5 before vitri¢cation. (A) 2 mol% FP,
31‡C. The QH domains and inclusions of disordered intermediates (arrow), that are common in pure DiPoPE dispersions at the same
temperature (Fig. 3), are rare in this sample. The most common structures are MLVs (asterisks). (B) 5 mol% FP, 31‡C. in DiPoPE.
At this higher FP concentration, the most common structures are LUVs and a few oligolamellar vesicles. There are also many fewer
MLVs than in 2 mol% FP specimens. Most of the specimens showed dispersed LUVs. A denser-than-usual ¢eld was selected here to
emphasize the small change in LUV size and structure. (C and D) 7 mol% FP, 33‡C. The same sort of morphology is observed as at
5 mol% FP, except that MLVs are even rarer. Small clusters of disordered intermediates (arrow) are infrequently observed, as at
5 mol% FP. (E) 15 mol% FP, 25‡C. Domains of disordered intermediates (center of ¢gure) are more common and larger than in A^
D. Many examples of ILAs are visible (small arrows). However, this specimen was made from an LUV dispersion that had been
stored for 6 days at 4‡C. Chemical degradation of DiPoPE in this case may have produced structures that would not normally occur
(see text).
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able for the TRC-TEM. We had some concerns
about the chemical stability of the DiPoPE that
was stored at pH 9.6, even though it was kept at
4‡C in this work and in the TRC-TEM work on
pure DiPoPE reported earlier [9]. We assessed the
rate of formation of impurities that lowered TH as
a function of the time of storage at pH 9.6 at 4‡C. At
appropriate times, samples of the LUVs were with-
drawn and loaded into the DSC (pre-cooled to 0‡C),
and the LUV dispersions were neutralized with an
equal volume of cold acetate bu¡er (to decrease the
pH to 5 and enable the phase transition at higher
temperatures). Then the DSC experiment was per-
formed. DSC data from thermograms obtained im-
mediately after production, and at times 24, 48, 120,
and 168 h after production, are displayed in Fig. 5.
The peak temperature of the endotherm drops by a
total of 3.5‡C after 1 day, 4‡C after 2 days, 7‡C after
5 days, and more than 8‡C after 7 days. The enthal-
py of the transitions drops rapidly after the ¢rst
5 days. However, it is clear that LUVs used within
24 h after production have a TH that is the same to
within 3.5‡C of freshly produced lipid.
In the present work, LUV dispersions were used
within 1^3 days after production, except as otherwise
noted in the ¢gure captions. Dynamic morphological
results on pure DiPoPE (Fig. 3A,B) and FP/DiPoPE
(Fig. 4A^D) dispersions were obtained on samples
that were less than 1 day old. In the work reported
in [9], LUV dispersions were used within 6^8 days of
production, and occasionally within 1 day. While the
samples kept for 6^8 days probably had transition
temperatures that were as much as 8‡C lower than in
freshly prepared LUVs, it is important to note that
the relevant dynamic morphologies associated with
transition intermediates was observed at tempera-
tures more than 22^38‡C below the original value
of TH [9]. In addition, the same dynamic morphology
was also observed in specimens prepared from LUV
dispersions that were less than 1 day old (i.e. in Figs.
1D,G and 3C of [9]), at temperatures 16^38‡C below
TH. These results cannot be explained in terms of a
reduction in TH due to DiPoPE hydrolysis. More-
over, control experiments on pure DiPoPE were per-
formed for the present paper (Fig. 3A,B) using LUV
dispersions produced less than 24 h of use, and gen-
erated the same morphological results as observed in
[9].
Therefore, the principal results of the morpholog-
ical study in [9] and in Figs. 3 and 4 of the present
work are not due to HII phases forming at a lower
than expected transition temperature. It is possible
that the hydrolysis products formed by DiPoPE deg-
radation may play a role in forming some of the
intermediate morphology in DiPoPE systems. Thin-
layer chromatography results (not shown) show that
about 3% of the DiPoPE in LUVs hydrolyzes after
24 h of storage in glycine bu¡er at 4‡C. However, it
should be noted that disordered intermediate arrays
and ILAs as imaged in Figs. 3 and 4 are not created
only in samples where lipid hydrolysis has occurred.
The same structures have been observed in large
numbers via freeze-fracture TEM (e.g. [23]) and via
TRC-TEM [9,24,25] in temperature-jumped DOPE-
Me LUV dispersions that were made and stored on
ice at pH 7.4. These are conditions under which lipid
degradation does not occur.
4. Conclusions
This research produced three principal results.
Fig. 5. DSC thermograms of acidi¢ed DiPoPE LUV disper-
sions. DiPoPE LUVs were stored for the times indicated on
each of the traces at 4‡C, before being acidi¢ed inside the DSC
cell at a temperature near 0‡C, and then scanned.
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First, the addition of 3^7 mol% of FP, the fusion
peptide of in£uenza hemagglutinin, to DiPoPE indu-
ces QII phase formation along with HII phase, where-
as the QII phase is not observed in the pure lipid
system under the same circumstances. This is dem-
onstrated by the observation of QII phase X-ray dif-
fraction patterns in the FP/DiPoPE system and not
in pure DiPoPE incubated under the same conditions
(Fig. 1, Tables 1 and 2).
Second, the TRC-TEM shows that e¡ect of FP
occurs very early in the overall transition process,
which was described in earlier TRC-TEM research
[9,24,25]: addition of 2^7 mol% FP inhibits the for-
mation of intermembrane intermediates in the phase
transition when the systems are compared at a tem-
perature where intermediate morphology is abundant
in pure DiPoPE (Figs. 2^4).
Third, the X-ray di¡raction data show that FP
does not decrease the spontaneous radius of curva-
ture of the lipid system and, if anything, slightly in-
creases it (Table 3). This is in contrast with earlier
research that reported that viral fusion peptides at
lower concentrations decreased the spontaneous cur-
vature of the host lipid system, and induced non-
lamellar phases at lower temperatures than observed
in the pure lipid system [7,8,22]. Clearly, in this sys-
tem, in the concentration range of 2^7 mol%, the
peptides have a very di¡erent e¡ect. These two ob-
servations, however, are not necessarily contradic-
tory. One possibility is that there is more self-asso-
ciated peptide in the membrane at the higher peptide
mole fractions used in the present study and that
these peptide oligomers have a di¡erent e¡ect on
TH than do peptide monomers in the membrane.
The other consideration is that the interconversion
between HII and QII phases can exhibit very slow
kinetics. In the earlier work at low peptide concen-
tration, there is very little QII phase formed and the
transition from the LK to HII phase is observed,
while at high peptide concentration the most pre-
dominant phases are the LK and QII phases and it
is not possible to measure TH. The temperature of
conversion to the cubic phase may not be solely de-
pendent on membrane curvature.
The mechanism by which FP produces QII phase
in preference to HII phase in DiPoPE is not clear.
Earlier [9], we suggested that hydrophobic peptides,
like FP might favor production of ILAs (fusion
pores, which are QII phase precursors) from critical
intermediates know as transmonolayer contacts
(TMCs). This could come about if the membrane-
absorbed peptides lowered the rupture tension of
the DiPoPE bilayers. If the central bilayer diaphragm
of a TMC ruptures, it forms an ILA. If the dia-
phragm is stable, the TMCs can live long enough
to aggregate with other TMCs to form HII phase
precursors [5,9]. It has been shown that incubation
of lipid vesicles with aqueous solutions containing
FP does in fact lower the rupture tension substan-
tially (by ca. 60% or more; [26]). Rupture of TMCs
to form ILAs would both delay TMC aggregation
into HII precursors and make ILAs available to as-
semble into QII phase lattices [5], which do not occur
in the pure lipid. In addition, the presence of ILAs in
multilamellar aggregates should also hinder HII
phase formation [5]. Therefore, our observations,
and those of Longo et al. [26], are quite consistent
with our hypothesis that FP induces QII phase for-
mation by lowering the membrane rupture tension
and destabilizing TMCs.
Hydrophobic peptides could conceivably increase
membrane fusion rates in vivo via the same sort of
mechanism, which is thought to involve similar types
of lipid intermediates. However, with regard to the
role of FP in in£uenza hemagglutinin-mediated fu-
sion, it must be noted that the fusion peptide would
have to access the diaphragm of the TMC from with-
in the virus or the cytoplasmic side of the target cell
membrane in order to have the e¡ect we postulate. In
vivo the fusion peptide can only enter the fusion
intermediate from outside of the hypothetical TMC
(i.e. from the extracellular space). The FP can only
have access to the membrane diaphragm of the TMC
if it can somehow traverse the exterior monolayers of
the fusion intermediate. Thus it is not clear that this
behavior of FP is relevant to the mechanism of viral
protein-induced membrane fusion. However, it is
possible that the hydrophobic portions of other pro-
teins, or perhaps the intra-viral domains of fusion
catalyzing proteins or of neighboring proteins, could
be fusogenic through this type of mechanism.
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